Gene · 5921
Papers3,549
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
621 to 640 of 3,549
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Lateralized overgrowth with vascular malformation caused by a somatic PTPN11 pathogenic variant: Another piece added to the puzzle of mosaic RASopathies. | Genes Chromosomes Cancer | 2022 | 35778969 | PubTator, text mining | PubMed |
| Comprehensive Urinomic Identification of Protein Alternatives to Creatinine Normalization for Diagnostic Assessment of Lupus Nephritis. | Front Immunol | 2022 | 35774777 | PubTator, text mining | PubMed |
| Rho GTPase-activating protein 35 suppresses gastric cancer metastasis by regulating cytoskeleton reorganization and epithelial-to-mesenchymal transition. | Bioengineered | 2022 | 35758029 | PubTator, text mining | PubMed |
| Insights Into Platelet-Derived MicroRNAs in Cardiovascular and Oncologic Diseases: Potential Predictor and Therapeutic Target. | Front Cardiovasc Med | 2022 | 35757325 | PubTator, text mining | PubMed |
| Symptomatic and Stenotic Developmental Venous Anomaly with Pontine Capillary Telangiectasia: A Case Report with Genetic Considerations. | NMC Case Rep J | 2022 | 35756188 | PubTator, text mining | PubMed |
| New Targets for Antiviral Therapy: Inhibitory Receptors and Immune Checkpoints on Myeloid Cells. | Viruses | 2022 | 35746616 | PubTator, text mining | PubMed |
| Clinical and Molecular Spectrum of Sporadic Vascular Malformations: A Single-Center Study. | Biomedicines | 2022 | 35740480 | PubTator, text mining | PubMed |
| ASK1-Interacting Protein 1 Acts as a Novel Predictor of Type 2 Diabetes. | Front Endocrinol (Lausanne) | 2022 | 35712257 | PubTator, text mining | PubMed |
| Neurodevelopmental disorders, immunity, and cancer are connected. | iScience | 2022 | 35712080 | PubTator, text mining | PubMed |
| Comparative study on the mutation spectrum of tissue DNA and blood ctDNA in patients with non-small cell lung cancer. | Transl Cancer Res | 2022 | 35706796 | PubTator, text mining | PubMed |
| Integrated genomic analyses of acral and mucosal melanomas nominate novel driver genes. | Genome Med | 2022 | 35706047 | PubTator, text mining | PubMed |
| Time-resolved proximity labeling of protein networks associated with ligand-activated EGFR. | Cell Rep | 2022 | 35705039 | PubTator, text mining | PubMed |
| Advances in Immunosuppressive Agents Based on Signal Pathway. | Front Pharmacol | 2022 | 35694243 | PubTator, text mining | PubMed |
| Mutations in ALK signaling pathways conferring resistance to ALK inhibitor treatment lead to collateral vulnerabilities in neuroblastoma cells. | Mol Cancer | 2022 | 35689207 | PubTator, text mining | PubMed |
| Quantitative phosphoproteomics reveal cellular responses from caffeine, coumarin and quercetin in treated HepG2 cells. | Toxicol Appl Pharmacol | 2022 | 35688186 | PubTator, text mining | PubMed |
| Surgical management of a congenital arteriovenous fistula of the forearm. | J Surg Case Rep | 2022 | 35685292 | PubTator, text mining | PubMed |
| RNF43 G659fs is an oncogenic colorectal cancer mutation and sensitizes tumor cells to PI3K/mTOR inhibition. | Nat Commun | 2022 | 35676246 | PubTator, text mining | PubMed |
| Longitudinal genomic alternations and clonal dynamics analysis of primary malignant melanoma of the esophagus. | Neoplasia | 2022 | 35661532 | PubTator, text mining | PubMed |
| A pyroptosis-related gene signature predicts prognosis and immune microenvironment in hepatocellular carcinoma. | World J Surg Oncol | 2022 | 35659304 | PubTator, text mining | PubMed |
| Integrating intracellular nanovesicles into integrin trafficking pathways and beyond. | Cell Mol Life Sci | 2022 | 35657500 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5921/papers?page=32